Conference Speakers
Cultural Speakers
Cultural practices, beliefs, and norms play a very important role not only in delivering health care to clients and patients, but also in how that health care is received and what outcomes are possible. Diversity within those beliefs and practices, and as a result of available resources or social economic/demographic circumstances, must be fully understood in order for health care professionals to provide the best care possible no matter where they are in the world, or what culture they are practicing within.
At GOLD Perinatal Care, we understand the importance of Culture and Diversity in health care, and we are working hard to bring you speakers and presentations from around the world that will help you understand the patients and clients you are working with. Discovering how health care is provided and received in other countries and cultures around the world can have a positive impact on our own professional practice. Given that culture is defined by much more than political borders, GOLD Perinatal Care invites speakers to share their knowledge and expertise about perinatal health care from a geographically-based focus or a people-group focus from within a particular set of beliefs, lifestyle or minority. This year, our Culture and Diversity speakers will be presenting on:


Annet Mulder first became interested in breastfeeding in the year 2000, when she became a mother for the first time. During and because of her own breastfeeding experiences, in 2002 she became a volunteer with the Dutch breastfeeding Organization and in 2008 sat for and passed the exam administered by the International Board of Lactation Consultant Examiners. As an International Board Certified Lactation Consultant, she now
Annet Mulder first became interested in breastfeeding in the year 2000, when she became a mother for the first time. During and because of her own breastfeeding experiences, in 2002 she became a volunteer with the Dutch breastfeeding Organization text text text text more name mulder first became interested in breastfeeding in the year 2000, when she became.


Speakers (5191)
- is a Patient Advocate for Lung Cancer, Cancer Research, Clinical Trials and Timely Access to Latest Treatment in India.
- was caregiver & spouse of “Kusum Malik Tomar” a patient of stage 4 Lung Cancer (never-smoker) metastatic to brain, bones & others, who survived 7 long years with Hope, Courage, Research Medicines & Clinical Trials.
- has co-founded India’s 1st Oncogene-Focused Patient support group ‘ALK Positive India’ and also co-founded "Rise To Survive Cancer" an initiative for patient advocacy for Lung Cancer, Cancer Research, Clinical Trials and Timely Access to Latest Treatment in India.
- member of advisory board for cancer research initiative and faculty for cancer awareness programs for Government of India, research centres and many non-profits
- successfully led campaigns to bring many latest cancer medicines in India for patients access, in record time.
- key note speaker and panellist at many national and international conferences and seminars.
- member of IASLC and National Cancer Grid India
- IASLC WCLC 2018 Education Award Winner
- Vivek & Kusum’s story & advocacy work has featured in many national and international media including ‘The Week’, ‘The Hindu’, ‘Zee news’, ‘NDTV’, ‘Big FM’, ‘Josh Talks’, ‘Bloomberg’, ‘Aljazeera’ etc. and also part of a book on inspirational stories called "God is not fair?"
My position as Professor of Research Ethics is unique in that I am embedded in all aspects of translational science conducted at Winship Cancer Institute. This has made possible cutting-edge empirical ethics research into areas of ethical concern, including informed consent and justice issues in clinical trials. The ethics program, which I lead, is currently addressing disparate enrollment in clinical trials in the United States. I was one of two faculty who conducted a week long course in Research Ethics in Uganda, which addressed the issue of well-resourced countries conducting trials in low-resourced countries. During the Uganda course we directly addressed the issue surrounding HIV trials and stigma. We worked with traveling singers who were attempting to destigmatize HIV and encourage screening. Currently, I am the research ethicist for the Winship Lung SPORE and work actively with lung cancer investigators to ensure that the lung cancer clinical trials are ethical.
Dr. West is an Associate Clinical Professor in Medical Oncology, a specialist in thoracic oncology, and serves as Executive Director of Employer Services at City of Hope Comprehensive Cancer Center. He was previously Medical Director of the Thoracic Oncology Program at the Swedish Cancer Institute in Seattle.
Dr. West received an MPhil in Experimental Biology from Cambridge University on a Fulbright Scholarship and a medical degree (magna cum laude) from Harvard Medical School, where Dr. West also conducted research as a Howard Hughes Medical Student Fellow. His postdoctoral training included an internship and residency in internal medicine at the Harvard-affiliated Brigham and Women’s Hospital Boston, MA, followed by a fellowship in medical oncology at the Fred Hutchinson Cancer Research Center/University of Washington in Seattle, WA.
In late, 2002, he moved to Swedish Cancer Institute in Seattle, where he served for over 16 years as Medical Director of the Thoracic Oncology Program, overseeing a broad array of clinical care and research responsibilities. In March, 2019, he moved to the Los Angeles area to dedicate his focus on innovative approaches to delivering sub-specialist expertise across a broader geography, using tools such as remote case reviews and telemedicine consultations.
He has authored dozens of papers and chairs several CME programs and symposia internationally on thoracic oncology, novel educational approaches, and social media in cancer care.
In addition to these activities, he is the Founder & President of Global Resource for Advancing Cancer Education (GRACE); Web Editor for JAMA Oncology; regular correspondent for Medscape; and contributing author and section editor in Lung Cancer for UpToDate.
He is also a staff in Section of Knowledge Integration of Center for Cancer Genomics and Advanced Therapeutics and Rare Cancer Center, director of patient supportive organizations, secretary general of JSMO (Japanese Society of Medical Oncology), panel member of guideline and database committee in Japanese Lung Cancer Society, associate editor of Japanese Journal of Clinical Oncology and communication committee member of IASLC.